Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120166532 | 12016653 | 2 | F | 20151220 | 20160205 | 20160922 | PER | US-AMGEN-USASP2015137048 | AMGEN | 0.00 | F | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120166532 | 12016653 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK UNK, UNK | U | 125031 | SOLUTION FOR INJECTION | ||||||||
| 120166532 | 12016653 | 2 | SS | NEUPOGEN | FILGRASTIM | 1 | Unknown | UNK UNK, UNK | U | 0 | SOLUTION FOR INJECTION | ||||||||
| 120166532 | 12016653 | 3 | C | PACLITAXEL. | PACLITAXEL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120166532 | 12016653 | 1 | Product used for unknown indication |
| 120166532 | 12016653 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120166532 | 12016653 | Application site erythema | |
| 120166532 | 12016653 | Application site haemorrhage | |
| 120166532 | 12016653 | Bone pain | |
| 120166532 | 12016653 | Neutrophil count decreased | |
| 120166532 | 12016653 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |